IGMS – igm biosciences, inc. (US:NASDAQ)
Stock Stats
News
IGM Biosciences, Inc. (NASDAQ: IGMS) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $21.00 price target on the stock.
IGM Biosciences, Inc. (NASDAQ: IGMS) had its price target raised by analysts at Stifel Nicolaus from $25.00 to $27.00. They now have a "buy" rating on the stock.
IGM Biosciences GAAP EPS of -$1.01 misses by $0.19, revenue of $0.52M beats by $0.28M [Seeking Alpha]
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]
Form 4 IGM Biosciences, Inc. For: Dec 31 Filed by: Topsoe Jakob Haldor
Form 4 IGM Biosciences, Inc. For: Dec 31 Filed by: Topsoe Christina Teng
Form 4 IGM Biosciences, Inc. For: Dec 31 Filed by: Thompson Elizabeth H.Z.
Form 4 IGM Biosciences, Inc. For: Dec 31 Filed by: BEHRENS M KATHLEEN
Form 4 IGM Biosciences, Inc. For: Dec 31 Filed by: Baker Brothers Life Sciences LP
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.